Quantcast
Last updated on April 19, 2014 at 7:10 EDT

Latest Transcription factors Stories

2013-05-01 16:31:20

RICHMOND, Calif., May 1, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its first quarter 2013 financial results on Wednesday, May 8, 2013, after the market closes. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the financial results and discuss other business matters. (Logo:...

2013-04-24 16:26:02

RICHMOND, Calif., April 24, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(® )development programs and an overview of the company's business strategy at 12:50 pm ET on Wednesday, May 1, 2013, at the 12(th) Annual Needham Healthcare Conference which will be held in New York. (Logo:...

2013-04-23 22:38:17

Epoxide hydrolase inhibition and thiazolidinediones Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the...

2013-04-10 10:55:21

Understanding how oncogenes affect the body clock may help create better cancer treatments The Myc oncogene can disrupt the 24-hour internal rhythm in cancer cells. Postdoctoral fellow Brian Altman, PhD, and graduate student Annie Hsieh, MD, both from the in the lab of Chi Van Dang, MD, PhD, director of the Abramson Cancer Center, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, present their data in the "Metabolic Pathway Regulation in...

2013-03-20 23:00:30

Chronic inflammation contributes to a host of medical conditions affecting people, companion pets and horses but being proactive can help keep that inflammation under control. Cur-OST® is a curcumin based all natural anti-inflammatory supplement that has demonstrated the ability to reduce chronic inflammation through modulation of two key transcription factors; NF-kB and NRF2, thereby reducing inflammation and also enhancing the immune response which may impact a variety of clinical...

Obesity Study Looks At Brown Fat Cells
2013-03-15 06:11:35

Enid Burns for redOrbit.com — Your Universe Online Many of us don't know the difference between brown fat cells and white fat cells. But researchers at Perelman School of Medicine at the University of Pennsylvania, led by Patrick Seale, Ph.D., are looking at brown fat cells to better understand how they develop. The researchers believe that the brown fat cell makes heat for the body, which has helped mammals cope with the cold. New theories say the warmth generated in brown fat...

2013-03-13 17:47:27

On the football field, the neophyte fan focuses on the receiver, whose daring catch and dash for the goal line captures the attention. However, focusing on that one player means the fan misses the contributions of the quarterback, the blockers and the other players who make that run happen. The same is true in the cell, where too often a single finding about one protein, enzyme or receptor seems to solve a problem. In an online report in the journal Nucleic Acids Research, Dr. Michael...

2013-03-05 16:25:45

RICHMOND, Calif., March 5, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(® )development programs and an overview of the company's business strategy at 4:45 pm ET on Wednesday, March 13, 2013, at the Barclays Global Healthcare Conference which will be held in Miami. (Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO) The...

2013-02-27 16:27:20

RICHMOND, Calif., Feb. 27, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and development, will provide an update on the progress of Sangamo's ZFP Therapeutic(® )development programs and an overview of the company's business strategy at 10:40 am ET on Wednesday, March 6, 2013, at the 33(rd) Annual Cowen and Company Health Care Conference which will be held in Boston. (Logo:...

2013-02-25 10:43:41

Protein uses multiple means to help cells cope when oxygen runs low A protein known for turning on genes to help cells survive low-oxygen conditions also slows down the copying of new DNA strands, thus shutting down the growth of new cells, Johns Hopkins researchers report. Their discovery has wide-ranging implications, they say, given the importance of this copying – known as DNA replication – and new cell growth to many of the body's functions and in such diseases as cancer....